NCT04306692

Myo-inositol Versus Clomiphene Citrate in PCOS

Myo-inositol Versus Clomiphene Citrate as First Line Treatment for Ovulation Induction in PCOS

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: University Hospital, Ghent · Academic / Other
• Sex: Female
• Age: 18 Years – 40 Years
• Healthy volunteers: Not accepted

Summary

Specific aim: To compare inositol and the golden standard first line treatment of ovulation induction, namely clomiphene citrate.

Conditions

• Ovulation Induction
• Polycystic Ovary Syndrome
• Clomiphene
• Inositol

Interventions

Type	Name	Description
DRUG	Myo-inositol	2 x 1 bag per day, per os (subjects can take myo-inositol during the meal but it is not obliged).
DRUG	Clomiphene Citrate	Each tablet contains 50 mg of clomiphene citrate which means 33,9 mg of clomiphene. Other constituents are sucrose, lactose monohydrate, corn starch, pregelatinized starch, yellow iron oxide (E172) and magnesium stearate (E470b). Dosing: 1 tablet per day from cycle day 3 until 7 (extremes included), stepping up until a maximum dose of 3 tablets per day for 5 consecutive days.

Timeline

• Start date: 2020-07-02
• Primary completion: 2021-04-20
• Completion: 2022-01-31
• First posted: 2020-03-13
• Last updated: 2022-12-21

Locations

1 site across 1 country: Belgium